Market News & Analysis


Market Brief: Equities Unwind Gains Ahead Of UK Brexit Vote

,

FX Brief:

  • China’s GDP hit a fresh multi-decade low, expanding ‘just’ 6% YoY and below expectations of 6.1% (down form 6.2% prior). Taking the edge off-of weak growth, industrial output expanded at 5.8%, above 5% consensus whilst retail sales also beat at 7.8% YoY versus 7.5% forecast. So, whilst growth was a disappointment, the rest average it out, hence the muted market reaction from the likes of AUD and NZD.
  • RBA’s Governor Philip Lowe thinks that negative rates are “extraordinarily unlikely” and that low rates along are not likely to stimulate investment. “In my view we’re clearly in the world of diminishing returns to monetary easing…" which could be taken to mean RBA will favour QE of negative rates.
  • Razor-thin ranges for the majors. USD/JPY is consolidating in a small range above the pivotal level if 108.50. EUR/USD is brimming at its highs after closing above 1.1100 yesterday. GBP/USD is treading water around 1.2850. NZD I the strongest major (as seen with it dominating strength on the FX dashboard). GBP/NZD has fallen -0.8% but, given high levels of volatility it has pushed the ATR up, hence it ‘only’ covering 50% of its ATR.
  • AUD/NZD is the only pair to be near its ATR and, with little news flow expected to directly impact the cross, the move could be done for the day and could be prone to mean reversion.



Equity Brief:

  • Some profit-taking activities can be seen in several Asian stock markets in today’s Asian session on the backdrop of mixed economic data from China. China Q3 GDP growth has slowed to 6.0% y/y (below consensus of 6.1% y/y), its lowest growth rate since Q1 1992 while Industrial Production has managed to beat expectations with a growth rate at 5.8% y/y in Sep (5.0% y/y consensus).
  • Despite EU and U.K has agreed to a Brexit deal and the ball now is back in U.K for a parliamentary vote schedule this Sat. Thus, some unwinding of “risk on “positions can be justified as we head into the weekend with the possibility that U.K PM Boris Johnson may not be able gather enough votes in the parliament as the Northern Ireland DUP, which the government relies on for support in key votes has reiterated no support on the latest deal.
  • The ASX 200 has continued to decline for the 2nd consecutive day where it has shed -0.63% led by major healthcare related stocks that have offshore operations where revenue can be dented due to a weaker USD seen in the past week. Share prices of CSL and Cochlear have declined by -1.1% and -0.8% respectively.
  • Japan’s Nikkei 225 has managed to inch out a modest gain of 0.20% led by several major technology stocks reinforced by upbeat earnings from Taiwan’s TSMC, the world’s largest contract chipmaker. Murata Manufacturing, Fanuc and Keyence have recorded gains between 1.3% to 2.4%.

Up Next

  • No major economic data points today, so it’s all about Brexit as we head towards the weekend.


Related Analysis:
Volatility Assessment Ahead Of Brexit Deal Vote | GBP/USD, GBP/JPY, EUR/GBP
Market Brief: BoJo’s Brexit Breaks Through the EU
GBP/JPY on watch as focus turns to parliament Brexit vote
Markets rejoice! Brexit deal now faces the fire




Matt Simpson and Kelvin Wong both contributed to this article

*Data from Refinitiv. Index names may not reflect tradable instruments and not all markets are available in all regions.



From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.